Filtros de búsqueda

Lista de obras de

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis

artículo científico publicado en 2014

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis

artículo científico publicado en 2018

Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease

artículo científico publicado en 2018

Factors associated with short- and long-term outcomes of therapy for Crohn's disease

artículo científico publicado en 2014

IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease

scientific article published on 01 January 2020

Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis

scientific article published on 01 August 2019

Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension

artículo científico publicado en 2018

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients with Crohn's Disease

artículo científico publicado en 2018

Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies

scientific article published on 20 July 2016

Population Pharmacokinetics and Exposure-Response Modeling of Golimumab in Adults With Moderately to Severely Active Ulcerative Colitis

scientific article published on 22 January 2020

Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis

artículo científico publicado en 2013

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis

artículo científico publicado en 2013

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

artículo científico publicado en 2016

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

artículo científico publicado en 2019

Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda